Your browser doesn't support javascript.
loading
Optimization of a Novel Mandelamide-Derived Pyrrolopyrimidine Series of PERK Inhibitors.
Stokes, Michael E; Surman, Matthew D; Calvo, Veronica; Surguladze, David; Li, An-Hu; Gasparek, Jennifer; Betzenhauser, Matthew; Zhu, Guangyu; Du, Hongwen; Rigby, Alan C; Mulvihill, Mark J.
  • Stokes ME; HiberCell Inc., 619 West 54th Street, New York, NY 10019, USA.
  • Surman MD; Curia, 26 Corporate Circle, Albany, NY 12203, USA.
  • Calvo V; HiberCell Inc., 619 West 54th Street, New York, NY 10019, USA.
  • Surguladze D; HiberCell Inc., 619 West 54th Street, New York, NY 10019, USA.
  • Li AH; HiberCell Inc., 619 West 54th Street, New York, NY 10019, USA.
  • Gasparek J; Curia, 1001 Main Street, Buffalo, NY 14203, USA.
  • Betzenhauser M; Curia, 1001 Main Street, Buffalo, NY 14203, USA.
  • Zhu G; Curia, 1001 Main Street, Buffalo, NY 14203, USA.
  • Du H; Pharmaron Beijing Co., Ltd., No. 6, TaiHe Road, BDA, Beijing 100176, China.
  • Rigby AC; HiberCell Inc., 619 West 54th Street, New York, NY 10019, USA.
  • Mulvihill MJ; HiberCell Inc., 619 West 54th Street, New York, NY 10019, USA.
Pharmaceutics ; 14(10)2022 Oct 19.
Article en En | MEDLINE | ID: mdl-36297668